New system enhances the OptiMesh platform, giving surgeons greater flexibility to incorporate expandable implant technology into their preferred TLIF approach.
Spineology Announces New OptiMesh® TLIF System, Expanding Surgical Access and Procedural Versatility

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology, a leader in conforming, patient-specific spinal implant technology, today announced the introduction of the new OptiMesh® TLIF System. The latest addition to the company's established OptiMesh expandable implant platform offers enhanced access solutions designed to accommodate a range of surgical approaches and techniques.
The OptiMesh implant offers versatility across open, mini-open, and ultra-minimally invasive (Ultra-MIS) spinal fusion procedures. The new TLIF System further expands these options, supporting implant delivery through traditional TLIF approaches while allowing surgeons to maintain their established techniques and workflows.
While OptiMesh is one of the few expandable implant solutions that can be delivered through an endoscopic and Ultra-MIS approach, a growing number of surgeons are incorporating the technology into traditional TLIF procedures. Supported by clinical evidence and experience, OptiMesh features a conforming, patient-specific design that expands to the size of a traditional ALIF implant and can achieve up to 20 degrees of lordotic shape. These capabilities help surgeons address key surgical objectives, including disc height restoration, alignment, and long-term stabilization*.
“OptiMesh is one of the most proven expandable implant solutions on the market today. The new OptiMesh TLIF System builds on the platform's flexibility, providing enhanced access solutions that make it easier for surgeons to incorporate the technology into their existing surgical workflows. OptiMesh truly conforms to both a surgeon's practice and a patient's unique anatomical requirements,” said Brian Snider, Chief Executive Officer, Spineology.
The introduction of the OptiMesh TLIF System represents another step in Spineology's commitment to advancing its spinal implant portfolio and addressing the evolving needs of spine surgeons and their patients.
*OptiMesh is cleared for use with supplemental posterior fixation.
About Spineology
Spineology Inc. are the pioneers of Conform and Expand™ technology, a novel development method used in the design of spinal expandable implants. Spineology’s core portfolio, OptiMesh® is the only conforming patient specific spinal implant on the market. OptiMesh is backed with IDE level data which further sets the company apart from traditional fusion procedures. OptiMesh is designed to enable surgeons to support outcomes, and patient recovery while minimizing tissue disruption. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.
For more information about Spineology, visit Spineology.com, and follow us on LinkedIn, or X.
Contacts
For Media Inquiries:
Amanda Bloom
Executive Vice President of Marketing
651-256-8533
abloom@spineology.com
Author
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
Spineology introduced the OptiMesh TLIF System, expanding its expandable implant platform. This strategic move aims to boost market adoption by offering enhanced access solutions, allowing surgeons to integrate the technology into their preferred traditional TLIF approaches and existing workflows. The system supports both traditional and ultra-minimally invasive procedures, broadening its competitive reach and strengthening Spineology's spinal implant portfolio.
- The new system enhances market access by accommodating diverse surgical approaches, including traditional TLIF.
- Spineology's strategy focuses on increasing adoption by seamlessly integrating technology into existing surgeon workflows.
PhD Lens: Clinical and outcomes impact
The OptiMesh TLIF System introduces an expandable implant featuring a conforming, patient-specific design. This technology expands to ALIF implant dimensions and can achieve up to 20 degrees of lordosis, addressing key surgical objectives like disc height restoration and alignment. Supported by clinical evidence, including IDE-level data, it offers versatility across open, mini-open, and ultra-minimally invasive spinal fusion procedures, requiring supplemental posterior fixation.
- The implant's mechanism involves conforming expansion to achieve patient-specific disc height and lordotic correction.
- Clinical evidence, including IDE-level data, supports its application in various TLIF approaches for spinal fusion.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.